These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29180488)

  • 1. Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination.
    Lin A; Liang F; Thompson EA; Vono M; Ols S; Lindgren G; Hassett K; Salter H; Ciaramella G; Loré K
    J Immunol; 2018 Jan; 200(1):286-294. PubMed ID: 29180488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
    Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
    mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells.
    Jitschin R; Saul D; Braun M; Tohumeken S; Völkl S; Kischel R; Lutteropp M; Dos Santos C; Mackensen A; Mougiakakos D
    J Immunother Cancer; 2018 Nov; 6(1):116. PubMed ID: 30396365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression.
    Pinton L; Solito S; Damuzzo V; Francescato S; Pozzuoli A; Berizzi A; Mocellin S; Rossi CR; Bronte V; Mandruzzato S
    Oncotarget; 2016 Jan; 7(2):1168-84. PubMed ID: 26700461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells.
    Azzaoui I; Uhel F; Rossille D; Pangault C; Dulong J; Le Priol J; Lamy T; Houot R; Le Gouill S; Cartron G; Godmer P; Bouabdallah K; Milpied N; Damaj G; Tarte K; Fest T; Roussel M
    Blood; 2016 Aug; 128(8):1081-92. PubMed ID: 27338100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study.
    Chen H; Qin S; Lei A; Li X; Gao Q; Dong J; Xiao Q; Zhou J
    Int Immunopharmacol; 2017 Jun; 47():150-158. PubMed ID: 28407569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
    Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of polymorphonuclear myeloid-derived suppressor cells in endometriosis.
    Satake E; Koga K; Takamura M; Izumi G; Elsherbini M; Taguchi A; Makabe T; Takeuchi A; Harada M; Hirata T; Hirota Y; Wada-Hiraike O; Osuga Y
    J Reprod Immunol; 2021 Nov; 148():103371. PubMed ID: 34517223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.
    Davids M; Pooran A; Smith L; Tomasicchio M; Dheda K
    Front Immunol; 2021; 12():676679. PubMed ID: 34149712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β Enhances the Anti-inflammatory Effect of Tumor- Infiltrating CD33+11b+HLA-DR Myeloid-Derived Suppressor Cells in Gastric Cancer: A Possible Relation to MicroRNA-494.
    Moaaz M; Lotfy H; Elsherbini B; Motawea MA; Fadali G
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3393-3403. PubMed ID: 33247701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.
    Santegoets KCM; Gielen PR; Büll C; Schulte BM; Kers-Rebel ED; Küsters B; Bossman SAJFH; Ter Laan M; Wesseling P; Adema GJ
    Cancer Immunol Immunother; 2019 Jun; 68(6):937-949. PubMed ID: 30953118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heat-killed Mycobacterium tuberculosis prime-boost vaccination induces myeloid-derived suppressor cells with spleen dendritic cell-killing capability.
    Ribechini E; Eckert I; Beilhack A; Du Plessis N; Walzl G; Schleicher U; Ritter U; Lutz MB
    JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human monocytic myeloid-derived suppressor cells impair B-cell phenotype and function in vitro.
    Jaufmann J; Lelis FJN; Teschner AC; Fromm K; Rieber N; Hartl D; Beer-Hammer S
    Eur J Immunol; 2020 Jan; 50(1):33-47. PubMed ID: 31557313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral expansion of myeloid-derived suppressor cells is related to disease activity and damage accrual in inflammatory myopathies.
    Torres-Ruiz J; Absalón-Aguilar A; Reyes-Islas JA; Cassiano-Quezada F; Mejía-Domínguez NR; Pérez-Fragoso A; Maravillas-Montero JL; Núñez-Álvarez C; Juárez-Vega G; Culebro-Bermejo A; Gómez-Martín D
    Rheumatology (Oxford); 2023 Feb; 62(2):775-784. PubMed ID: 35766810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients.
    Giallongo C; Parrinello N; Tibullo D; La Cava P; Romano A; Chiarenza A; Barbagallo I; Palumbo GA; Stagno F; Vigneri P; Di Raimondo F
    PLoS One; 2014; 9(7):e101848. PubMed ID: 25014230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
    Jiang Y; Feng S; Ji J; Lin Z; Zhang X
    Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.